Linardos, Akis
Kushibar, Kaisar
Walsh, Sean
Gkontra, Polyxeni
Lekadir, Karim
Funding for this research was provided by:
European Union’s Horizon 2020 research and innovation programme (952103, 952103, 952103, 952103)
Article History
Received: 5 July 2021
Accepted: 2 February 2022
First Online: 3 March 2022
Competing interests
: Sean Walsh declares the following financial interests/personal relationships which may be considered as potential competing interests: within and outside the submitted work, is the recipient of grants/sponsored research agreements in the areas of medical imaging, artificial intelligence, data science, applied to the clinical specialties of oncology and respiratory medicine. He holds a leadership position within Oncoradiomics SA, has shares in the company Oncoadiomics SA, and is co-inventor of submitted patents on behalf Oncoradiomics SA. The rest of the authors declare no competing interests.